Need a specific person's email?
Browse CluePoints's employee directory (about 312 employees) and reveal verified emails free.
CluePoints's most common email format is First.Last@cluepoints.com (ex. John.Doe@cluepoints.com), used for 97% of cluepoints.com addresses. CluePoints uses 4 email patterns.
| Format | Example | Share of cluepoints.com |
|---|---|---|
| First.Last@cluepoints.comMost common | John.Doe@cluepoints.com | |
| First.MiddleLast@cluepoints.com | John.MichaelDoe@cluepoints.com | |
| FirMLast@cluepoints.com | JohMDoe@cluepoints.com | |
| LastFirst@cluepoints.com | DoeJohn@cluepoints.com |
Browse CluePoints's employee directory (about 312 employees) and reveal verified emails free.
Software DevelopmentWallonia, Belgium201-500 Employees
CluePoints develops software for risk-based quality management (RBQM) and data quality oversight in clinical trials. The platform applies advanced statistics and artificial intelligence to assess the quality, accuracy, and integrity of trial data during and after studies. It aligns with regulatory guidance from the FDA, EMA, ICH, and MHRA to support central and on-site monitoring, medical review, and quality risk management, enabling a holistic, risk-based approach to trial governance. Targeting organizations conducting clinical trials seeking robust data oversight, operational efficiency, and reduced regulatory submission risk, the product helps address these challenges through integrated monitoring and review processes. Based in Louvain-la-Neuve in the Wallonia region of Belgium, CluePoints operates as a specialized software provider within the life sciences technology landscape. It is a mid-sized company that has earned industry recognition, including a leadership appointment in January 2026 when Sinead Godkin was named Chief People Officer.
Most common format
First.Last@cluepoints.com
Example: John.Doe@cluepoints.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.